Prevalence of Atherosclerotic Disease in Asian Subjects Not on Lipid-lowering Agents, But With at Least Two CVD Risk Factors

AstraZeneca1 site in 1 country2,609 target enrollmentOctober 2009

ConditionsCardiovascular Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Cardiovascular Disease
Sponsor: AstraZeneca
Enrollment: 2609
Locations: 1
Primary Endpoint: Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs
Status: Completed
Last Updated: 15 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to obtain the distribution of measurements of the intima media thickness of carotid arteries in people with high cardiovascular risk.

Registry

clinicaltrials.gov

Start Date

October 2009

End Date

August 2010

Last Updated

15 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

AstraZeneca

Eligibility Criteria

Inclusion Criteria

•Provision of signed informed consent.
•Patients with at least two CVD risk factors but not on lipid-lowering agents

Exclusion Criteria

•Subjects with CHD, any conditions that may affect hs-CRP levels.
•Subjects on any lipid-lowering drug treatment within the last 3 months prior study entry.

Outcomes

Primary Outcomes

Measurement of Carotid Intima Media Thickness of people with high risk of cardiovascular disease but not on lipid lowering drugs

Time Frame: IIMT measurements taken only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months)

Secondary Outcomes

Lipid profile of people with high risk of cardiovascular disease but not on lipid lowering drugs(Blood sampling only once, either on Visit 1 or Visit 2 (time gap between V1 and V2 should be less than 3 months))